LEXX
What one share of Lexaria Bioscience holds
Pharmaceutical Preparations
Lexaria Bioscience Corp. is a biotechnology company dedicated to the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”) using our patented DehydraTECHTM drug delivery technology.
Lexaria Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-05-31; the balance sheet is as of 2026-05-31.
| Sales | $0.01 |
|---|---|
| Profit | −$0.34 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.33 |
| Cash and investments | $0.14 |
| Book value | $0.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$1.20 | — | −$0.80 | — | $5.00 |
| 2011 | — | −$1.20 | — | $0.23 | — | $4.86 |
| 2015 | $0.01 | −$1.20 | $0.00 | −$1.13 | — | $0.53 |
| 2016 | $0.03 | −$0.87 | $0.00 | −$0.45 | — | $0.16 |
| 2017 | $0.03 | −$0.90 | $0.00 | −$0.79 | — | $1.22 |
| 2018 | $0.18 | −$2.70 | — | −$1.06 | — | $0.95 |
| 2019 | $0.09 | −$1.50 | $0.25 | −$1.41 | — | $0.95 |
| 2020 | $0.11 | −$1.47 | $0.00 | −$0.94 | — | $0.83 |
| 2021 | $0.16 | −$0.95 | — | −$0.91 | — | $2.28 |
| 2023 | $0.03 | −$1.01 | $0.01 | −$0.89 | — | $0.38 |
| 2024 | $0.04 | −$0.47 | $0.00 | −$0.40 | — | $0.41 |
| 2025 | $0.04 | −$0.66 | $0.00 | −$0.58 | — | $0.15 |